Diabetes, renal function, and cardiovascular risk following myocardial infarction: Lessons from the VALsartan in acute myocardial iNfarcTion trial (VALIANT)

被引：0
|
作者：
Anavekar, NS
Solomon, SD
Maggioni, AP
Belenkov, Y
Rouleau, JL
McMurray, JJV
Velazquez, EJ
Califf, RM
Pfeffer, MA
机构：
[1] Baker Heart Inst, Melbourne, Vic, Australia
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2006年 / 47卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：217A / 217A
页数：1
相关论文
共 50 条
  • [31] Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT)
    Reed, SD
    Radeva, JI
    Weinfurt, KP
    McMurray, JJV
    Pfeffer, MA
    Velazquez, EJ
    Allsbrook, JS
    Masselink, LE
    Sellers, MA
    Califf, RM
    Schulman, KA
    AMERICAN HEART JOURNAL, 2005, 150 (02) : 323 - 329
  • [32] Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial
    Moukarbel, George V.
    Signorovitch, James E.
    Pfeffer, Marc A.
    McMurray, John J. V.
    White, Harvey D.
    Maggioni, Aldo P.
    Velazquez, Eric J.
    Califf, Robert M.
    Scheiman, James M.
    Solomon, Scott D.
    EUROPEAN HEART JOURNAL, 2009, 30 (18) : 2226 - 2232
  • [33] Smoking and cardiovascular risk following myocardial infarction
    Jaatun, H
    Dickstein, K
    Snapinn, S
    EUROPEAN HEART JOURNAL, 2002, 23 : 361 - 361
  • [34] Renal dysfunction and cardiovascular outcome after acute myocardial infarction: results from Korea acute myocardial infarction registry
    Yim, S.
    Bae, E. H.
    Kim, S. W.
    Jeong, M. H.
    EUROPEAN HEART JOURNAL, 2011, 32 : 92 - 92
  • [35] Cardiovascular Risk Factors in acute Myocardial Infarction
    Sieghartsleitner, S.
    Ebner, C.
    Schmid, M.
    Eder, V.
    Sturmberger, T.
    Aichinger, J.
    Steringer-Mascherbauer, R.
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S314 - S315
  • [36] The effect of valsartan, captopril, or both on left ventricular size and function following high-risk myocardial infarction: The VALIANT Echo Study
    Solomon, SD
    Skali, H
    Anavekar, NS
    Van de Werf, F
    Barvik, S
    Ghali, JK
    Bourgoun, M
    Pfeffer, MA
    JOURNAL OF CARDIAC FAILURE, 2004, 10 (04) : S25 - S25
  • [37] Impaired renal function in acute myocardial infarction
    Lekston, Andrzej
    Kurek, Anna
    Tynior, Barbara
    CARDIOLOGY JOURNAL, 2009, 16 (05) : 400 - 406
  • [38] Renal function and anaemia in acute myocardial infarction
    de Carvalho, Leonardo Pinto
    McCullough, Peter A.
    Gao, Fei
    Sim, Ling Ling
    Tan, Huay Cheem
    Foo, David
    Ooi, Yau Wei
    Richards, A. Mark
    Chan, Mark Y.
    Yeo, Tiong-Cheng
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (02) : 1397 - 1401
  • [39] The effect of valsartan, captopril, or both on atherosclerotic events after myocardial infarction: An analysis of the VALIANT trial
    McMurray, JJV
    Solomon, SD
    Reed, SD
    Velazquez, EJ
    White, H
    Howlett, JG
    Maggioni, AP
    Kober, L
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (06) : S156 - S156
  • [40] Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT trial
    Sampson, Uchechukwu K.
    Pfeffer, Marc A.
    McMurray, John J. V.
    Lokhnygina, Yuliya
    White, Harvey D.
    Solomon, Scott D.
    EUROPEAN HEART JOURNAL, 2007, 28 (06) : 685 - 691
12345